Brookfield Asset Management (TSX:BAM.A) Just Exploded 31%: Should You Buy or Bail?

Brookfield Asset Management Inc. (TSX:BAM.A)(NYSE:BAM) just popped over 31% on good vaccine news that points to the pandemic’s end.

| More on:
Dice engraved with the words buy and sell

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Don’t look now, but shares of top-tier Canadian alternative asset manager Brookfield Asset Management (TSX:BAM.A)(NYSE:BAM) are soaring, with shares now up over 31% for November thus far.

Don’t say you weren’t warned about the timely gain that was to come, as I’ve been pounding the table on the stock for most of October, as most other investors threw in the towel on stocks that have been feeling the greatest impact from the coronavirus pandemic. Today, it’s now apparent that BAM was one of the babies that had been thrown out with the bathwater amid October’s vicious month-ending sell-off.

While shares of BAM have taken off, the name remains over 13% off its February 2020 all-time high, and the stock still looks ridiculously cheap, given the more favourable environment that now looks to be in the cards in 2021 and beyond.

Brookfield stock: The tides have finally turned

Brookfield’s retail real estate exposure has been a major sore spot for most of the year. With the curtain being pulled on two effective vaccines over the last two weeks, battered COVID-hit stocks finally have permission to rally, after months of hovering around in limbo. While the coast isn’t clear yet (coronavirus cases are surging uncontrollably in many localities), hope and earnings growth potential beyond 2020 seem to be overpowering the near-term reality of current crisis, which seems to be getter drastically worse by the day.

Indeed, markets are forward-looking, and that’s a major reason why I touted Brookfield Asset Management as one of my top picks going into November.

On October 30, I’d pounded the table on Brookfield Asset Management (I guess you could say “with a BAM!”): “Dragged down by its real estate exposure (malls in particular), Brookfield is now trading at a bargain-basement valuation that’s too good for most long-term thinkers to pass up.” I’d said in a prior piece. “With central banks committing to keeping interest rates near the floor for a longer duration of time, the appetite for alternative assets is likely to surge out of this pandemic. With more than enough liquidity in place to weather another storm of COVID cases, it’s tough to find a firm with a risk/reward in the same league as Brookfield Asset Management.”

Indeed, there are fewer and fewer places to find a suitable expected return with rates staying at the floor for at least another two years or so. Brookfield is a best-in-class alternative asset play and the fact that shares got cut nearly in half from peak to trough back in the February-March market crash goes to prove that Mr. Market is capable of making massive blunders with his pricing.

If you hesitated, though, you missed out on a very sharp rally. After the 6.6% single-day surge on Monday, Brookfield is now up year to date. And as investors look to rotate back into value, I’d say BAM stock has much more room to run, as we inch closer to the end of this horrific pandemic.

The Foolish bottom line

The assets under the hood of BAM are just far too good, given the low-rate environment and the unrewarding nature of most other alternative assets, including the likes of fixed-income securities.

While the name is no longer the same steal it was in late October, I still think it’d be a wise move to buy a half position in the name, with the intention of buying the other half should this market and BAM stock be overdue for a significant retracement following one of the most explosive rallies since March.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Brookfield Asset Management. The Motley Fool recommends BROOKFIELD ASSET MANAGEMENT INC. CL.A LV.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »